参考文献/References:
[1] Feldman T, Wasserman H S, Hermann H C,et al.Percutaneous mitral valve repair
using the edge-to-edge technique: six-month results of the EVEREST phase I
clinical trial[J]. Journal of the American College of Cardiology, 2005, 46(11):
2134-2140.
[2] Mauri L, Garg P, Massaro J M,et al.The EVEREST II Trial: design and
rationale for a randomized study of the evalve mitraclip system compared with
mitral valve surgery for mitral regurgitation[J]. American Heart Journal, 2010,
160(1): 23-29.
[3] Feldman T, Kar S, Elmariah S,et al.Randomized comparison of
percutaneous repair and surgery for mitral regurgitation 5-year results of
EVEREST II[J]. Journal of the American College of Cardiology, 2015, 66(25):
2844-2854.
[4] Ogara P T, Grayburn P A, Badhwar V,et al.2017 ACC Expert consensus
decision pathway on the management of mitral regurgitation: a report of the
american college of cardiology task force on expert consensus decision pathways
[J]. Journal of the American College of Cardiology, 2017, 70(19): 2421-2449.
[5] Seeburger J, Borger M A, Tschernich H,et al.Transapical beating heart
mitral valve repair[J]. Circulation: cardiovascular interventions, 2010, 3(6):
611-612.
[6] Colli A, Manzan E, Zucchetta F,et al.Transapical off-pump mitral valve
repair with neochord implantation: early clinical results[J]. International
Journal of Cardiology, 2016(204): 23-28.
[7] Gammie J S, Wilson P, Bartus K,et al.Transapical beating-heart mitral
valve repair with an expanded polytetrafluoroethy-lene cordal implantation
device[J]. Circulation, 2016, 134(3): 189-197.
[8] Gammie J S, Bartus K, Gackowski A,et al.Beating-heart mitral valve
repair using a novel ePTFE cordal implantation device: a prospective trial[J].
Journal of the American College of Cardiology, 2018, 71(1): 25-36.
[9] Wang S, Meng X, Luo Z,et al.Transapical beating-heart mitral valve
repair using a novel neochord implantation system[J]. Ann Thorac Surg, 2018,
165(5): 265-267.
[10] Siminiak T, Wu J C, Haude M,et al.Treatment of functional mitral
regurgitation by percutaneous annuloplasty: results of the TITAN trial[J].
European Journal of Heart Failure, 2012, 14(8): 931-938.
[11] Lipiecki J, Siminiak T, Sievert H,et al.Coronary sinus-based
percutaneous annuloplasty as treatment for functional mitral regurgitation: the
TITAN II trial[J]. Open Heart, 2016, 3(2): 411.
[12] Goldberg S L, Meredith I, Marwick T,et al.A randomized double-blind
trial of an interventional device treatment of functional mitral regurgitation
in patients with symptomatic congestive heart failure-trial design of the REDUCE
FMR study[J]. American Heart Journal, 2017(188): 167-174.
[13] Kim J H, Kocatur O, Ozturk C,et al.Mitral cerclage annuloplasty, a
novel transcatheter treatment for secondary mitral valve regurgitation.initial
results in swine[J]. Journal of the American College of Cardiology, 2009, 54(7):
638-651.
[14] Noble S, Vilarino R, Muller H,et al.Fatal coronary sinus and aortic
erosions following percutaneous transvenous mitral annuloplasty device[J].
EuroIntervention, 2011, 7(1): 148-150.
[15] Nickenig G, Schueler R, Dager A,et al.Treatment of chronic functional
mitral valve regurgitation with a percutaneous annuloplasty system[J]. Journal
of the American College of Cardiology, 2016, 67(25): 2927-2936.
[16] Orban M, Braun D, Orban M,et al.Established interventions for mitral
valve regurgitation: current evidence[J]. Herz, 2016, 41(1): 19-25.